Skip to main content
Premium Trial:

Request an Annual Quote

OncoGenome Sciences Inks $15.4M First Round

OncoGenome Sciences of Liege, Belgium, today announced a $15.4 million first-round funding led by Brank Brussels Lambert and a syndicate of European investors.


OncoGenome, founded in 2002 by Herman Spolders, a former vice president of business development and operations at Virco and headquartered at the medical school of the University of Liege, Belgium, is developing genomics-based diagnostic tests for cancer. The company has a US facility in Durham, NC.


Participating in the funder were PolyTechnos Venture-Partners of Munich, Germany; Life Sciences Partners of Amsterdam, Netherlands; and Belgium-based economic development investors: Technowal of Liege; Meusinvest of Liege; and SIBL, also of Liege, OncoGenome said in a statement.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.